Keyron Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series A
- (In Progress)
- Latest Deal Amount
-
$7.5M
- Investors
-
18
Keyron General Information
Description
Developer of a clinical-stage medical technology platform designed to provide incision-free and reversible metabolic intervention for people with severe obesity and metabolic disease. The company's platform offers a non-invasive, fully reversible approach that replicates the metabolic benefits of bariatric procedures, enabling patients seeking alternatives to medication and invasive surgery to access improved treatment options.
Contact Information
Website
www.keyron.comCorporate Office
- 103c Camley Street
- King's Cross
- London N1C 4PF
- England, United Kingdom
Corporate Office
- 103c Camley Street
- King's Cross
- London N1C 4PF
- England, United Kingdom
Keyron Timeline
Keyron Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series A) | $7.5M | In Progress | Pre-Clinical Trials | |||
| 5. Later Stage VC | 02-Feb-2026 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 08-Feb-2023 | Cancelled | Generating Revenue | |||
| 2. Seed Round | 17-Aug-2021 | $954K | $1.82M | Completed | Generating Revenue | |
| 1. Angel (individual) | 27-Feb-2019 | $870K | $870K | Completed | Startup |
Keyron Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary | ||||||||
| A Ordinary | ||||||||
| Ordinary | 10,185 | $0.000138 | $35.74 | $35.74 | 1x | $35.74 | 6.87% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Keyron Patents
Keyron Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230049289-A1 | Orally administrable intragastric balloon | Inactive | 21-Feb-2020 | ||
| WO-2021165899-A1 | Orally administrable intragastric balloon | Inactive | 21-Feb-2020 | ||
| AU-2017335310-A1 | Expandable intragastric device | Active | 28-Sep-2016 | ||
| AU-2017335310-B2 | Expandable intragastric device | Active | 28-Sep-2016 | ||
| EP-3518839-A1 | Expandable intragastric device | Active | 28-Sep-2016 | A61F5/003 |
Keyron Signals
Keyron Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| Lobi Holdings ApS | Corporation | Minority | ||
| Angel (individual) | Minority | |||
| Medeor Associates | Growth/Expansion | Minority |
Keyron FAQs
-
When was Keyron founded?
Keyron was founded in 2016.
-
Where is Keyron headquartered?
Keyron is headquartered in London, United Kingdom.
-
What is the size of Keyron?
Keyron has 8 total employees.
-
What industry is Keyron in?
Keyron’s primary industry is Therapeutic Devices.
-
Is Keyron a private or public company?
Keyron is a Private company.
-
What is Keyron’s current revenue?
The current revenue for Keyron is .
-
How much funding has Keyron raised over time?
Keyron has raised $3.55M.
-
Who are Keyron’s investors?
, , Lobi Holdings ApS, , and Medeor Associates are 5 of 18 investors who have invested in Keyron.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process